ROS-activated SHP-1 signaling underlies artesunate-mediated inhibition of EMT and STAT3-Driven prostate cancer progression.
- DOI
- 10.1016/j.abb.2026.111003
- Published
- 2026 Sep 19
- Container
- Archives of biochemistry and biophysics
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.abb.2026.111003,
title = {ROS-activated SHP-1 signaling underlies artesunate-mediated inhibition of EMT and STAT3-Driven prostate cancer progression.},
author = {Jung YY and Nachiyappan A and Kim NY and Mohan CD and Bhol CS and Shanmugam MK and Siveen KS and Kumar AP and Deivasigamani A and Rangappa KS and Hui KM and Ahn KS},
year = {2026},
journal = {Archives of biochemistry and biophysics},
doi = {10.1016/j.abb.2026.111003},
url = {https://doi.org/10.1016/j.abb.2026.111003}
}RIS
TY - JOUR TI - ROS-activated SHP-1 signaling underlies artesunate-mediated inhibition of EMT and STAT3-Driven prostate cancer progression. AU - Jung YY AU - Nachiyappan A AU - Kim NY AU - Mohan CD AU - Bhol CS AU - Shanmugam MK AU - Siveen KS AU - Kumar AP AU - Deivasigamani A AU - Rangappa KS AU - Hui KM AU - Ahn KS PY - 2026 JO - Archives of biochemistry and biophysics DO - 10.1016/j.abb.2026.111003 UR - https://doi.org/10.1016/j.abb.2026.111003 ER -
APA
YY, J., A, N., NY, K., CD, M., CS, B., MK, S., KS, S., AP, K., A, D., KS, R., KM, H., & KS, A. (2026). ROS-activated SHP-1 signaling underlies artesunate-mediated inhibition of EMT and STAT3-Driven prostate cancer progression.. Archives of biochemistry and biophysics. https://doi.org/10.1016/j.abb.2026.111003
Source records
- pubmed · retrieved 2026-09-25T15:37:45.127Z
- europe-pmc · retrieved 2026-09-25T15:37:45.151Z